|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Suzman DL, Boikos SA and Carducci MA:
Bone-targeting agents in prostate cancer. Cancer Metastasis Rev.
33:619–628. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Larson SR, Zhang X, Dumpit R, Coleman I,
Lakely B, Roudier M, Higano CS, True LD, Lange PH, Montgomery B, et
al: Characterization of osteoblastic and osteolytic proteins in
prostate cancer bone metastases. Prostate. 73:932–940. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rajpar S and Fizazi K: Bone targeted
therapies in metastatic castration-resistant prostate cancer.
Cancer J. 19:66–70. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Johnstone RM, Adam M, Hammond JR, Orr L
and Turbide C: Vesicle formation during reticulocyte maturation.
Association of plasma membrane activities with released vesicles
(exosomes). J Biol Chem. 262:9412–9420. 1987.PubMed/NCBI
|
|
7
|
Denzer K, Kleijmeer MJ, Heijnen HF,
Stoorvogel W and Geuze HJ: Exosome: From internal vesicle of the
multivesicular body to intercellular signaling device. J Cell Sci.
113:3365–3374. 2000.PubMed/NCBI
|
|
8
|
Gusachenko ON, Zenkova MA and Vlassov VV:
Nucleic acids in exosomes: Disease markers and intercellular
communication molecules. Biochemistry (Mosc). 78:1–7. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Soung YH, Ford S, Zhang V and Chung J:
Exosomes in cancer diagnostics. Cancers (Basel). 9:82017.
View Article : Google Scholar
|
|
10
|
Zhou Y, Xia L, Lin J, Wang H, Oyang L, Tan
S, Tian Y, Su M, Wang H, Cao D and Liao Q: Exosomes in
nasopharyngeal carcinoma. J Cancer. 9:767–777. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ruivo CF, Adem B, Silva M and Melo SA: The
Biology of Cancer Exosomes: Insights and New Perspectives. Cancer
Res. 77:6480–6488. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou M, Chen J, Zhou L, Chen W, Ding G and
Cao L: Pancreatic cancer derived exosomes regulate the expression
of TLR4 in dendritic cells via miR-203. Cell Immunol. 292:65–69.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stevanato L, Thanabalasundaram L, Vysokov
N and Sinden JD: Investigation of Content, Stoichiometry and
Transfer of miRNA from Human Neural Stem CellLine Derived Exosomes.
PLoS One. 11:e01463532016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Greening DW, Gopal SK, Xu R, Simpson RJ
and Chen W: Exosomes and their roles in immune regulation and
cancer. Semin Cell Dev Biol. 40:72–81. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hashimoto K, Ochi H, Sunamura S, Kosaka N,
Mabuchi Y, Fukuda T, Yao K, Kanda H, Ae K, Okawa A, et al:
Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in
the bone metastatic microenvironment via targeting ARHGAP1 and
FAM134A. Proc Natl Acad Sci USA. 115:2204–2209. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Corcoran C, Rani S and O'Driscoll L:
miR-34a is an intracellular and exosomal predictive biomarker for
response to docetaxel with clinical relevance to prostate cancer
progression. Prostate. 74:1320–1334. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ye Y, Li SL, Ma YY, Diao YJ, Yang L, Su
MQ, Li Z, Ji Y, Wang J, Lei L, et al: Exosomal miR-141-3p regulates
osteoblast activity to promote the osteoblastic metastasis of
prostate cancer. Oncotarget. 8:94834–94849. 2017.PubMed/NCBI
|
|
18
|
Costa-Silva B, Aiello NM, Ocean AJ, Singh
S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, et
al: Pancreatic cancer exosomes initiate pre-metastatic niche
formation in the liver. Nat Cell Bio. 17:816–826. 2015. View Article : Google Scholar
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–8. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Möller A, House CM, Wong CS, Scanlon DB,
Liu MC, Ronai Z and Bowtell DD: Inhibition of Siah ubiquitin ligase
function. Oncogene. 28:289–296. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lazar E, Benedek T, Korodi S, Rat N, Lo J
and Benedek I: Stem cell-derived exosomes-an emerging tool for
myocardial regeneration. World J Stem Cells. 10:106–115. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Messenger SW, Woo SS, Sun Z and Martin
TFJ: A Ca2+ -stimulated exosome release pathway in
cancer cells is regulated by Munc13-4. J Cell Biol. 217:2877–2890.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ge R, Tan E, Sharghi-Namini S and Asada
HH: Exosomes in cancer microenvironment and beyond: Have we
overlooked these extracellular messengers? Cancer Microenviron.
5:323–332. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu S, Cao H, Shen B and Feng J:
Tumor-derived exosomes in cancer progression and treatment failure.
Oncotarget. 6:37151–37168. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mathivanan S, Fahner CJ, Reid GE and
Simpson RJ: ExoCarta 2012: Database of exosomal proteins, RNA and
lipids. Nucleic Acids Res. 40:(Database Issue). D1241–D1244. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Théry C, Ostrowski M and Segura E:
Membrane vesicles as conveyors of immune responses. Nat Rev
Immunol. 9:581–593. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bertoli G, Cava C and Castiglioni I:
MicroRNAs as biomarkers for diagnosis, prognosis and theranostics
in prostate cancer. Int J Mol Sci. 17:4212016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Filella X and Foj L: miRNAs as novel
biomarkers in the management of prostate cancer. Clin Chem Lab Med.
55:715–736. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang X, Yuan T, Liang M, Du M, Xia S,
Dittmar R, Wang D, See W, Costello BA, Quevedo F, et al: Exosomal
miR-1290 and miR-375 as prognostic markers in castration-resistant
prostate cancer. Eur Urol. 67:33–41. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Foj L, Ferrer F, Serra M, Arévalo A,
Gavagnach M, Giménez N and Filella X: Exosomal and non-exosomal
urinary miRNAs in prostate cancer detection and prognosis.
Prostate. 77:573–583. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rucci N and Angelucci A: Prostate cancer
and bone: The elective affinities. Biomed Res Int. 2014:1670352014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Keller ET, Zhang J, Cooper CR, Smith PC,
McCauley LK, Pienta KJ and Taichman RS: Prostate carcinoma skeletal
metastases: Cross-talk between tumor and bone. Cancer Metastasis
Rev. 20:333–349. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mohla S: Under-investigated area in
prostate cancer: Cross talk between the bone microenvironment and
prostate cancer bone metastasis. J Cell Biochem. 91:684–685. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Paget S: The distribution of secondary
growths in cancer of the breast. 1889. Cancer Metastasis Rev.
8:98–101. 1989.PubMed/NCBI
|
|
35
|
Engblom C, Pfirschke C, Zilionis R, Da
Silva Martins J, Bos SA, Courties G, Rickelt S, Severe N, Baryawno
N, Faget J, et al: Osteoblasts remotely supply lung tumors with
cancer-promoting SiglecFhigh neutrophils. Science. 358(pii):
eaal50812017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
San Martin R, Pathak R, Jain A, Jung SY,
Hilsenbeck SG, Piña-Barba MC, Sikora AG, Pienta KJ and Rowley DR:
Tenascin-C and Integrin α9 mediate interactions of prostate cancer
with the bone microenvironment. Cancer Res. 77:5977–5988. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Papaioannou G, Mirzamohammadi F and
Kobayashi T: MicroRNAs involved in bone formation. Cell Mol Life
Sci. 71:4747–4761. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yun HM, Park KR, Quang TH, Oh H, Hong JT,
Kim YC and Kim EC: 2,4,5-Trimethoxyldalbergiquinol promotes
osteoblastic differentiation and mineralisation via the BMP and
Wnt/β-catenin pathway. Cell Death Dis. 6:e18192015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee HS, Jung EY, Bae SH, Kwon KH, Kim JM
and Suh HJ: Stimulation of osteoblastic differentiation and
mineralisation in MC3T3-E1 cells by yeast hydrolysate. Phytother
Res. 25:716–723. 2011. View Article : Google Scholar : PubMed/NCBI
|
